A New Dawn in Cancer Detection: Freenome's Bold Move Towards Public Markets

A New Chapter for NCCN: Dr. Renuka Iyer Appointed Chief Medical Officer

The Pharmaceutical Pulse: A Year-End Reflection on Innovation, Politics, and Public Trust in 2025

The Anticipation Builds: ASH 2025 and the Evolving Landscape of Blood Cancer Therapies

Pharma's Unfolding Drama: 340B Clashes, Vaccine Progress, and Cancer Innovation

A New Dawn for Skin Cancer Patients: Citius Oncology Launches Lymphir in the US

AI Drug Discovery Takes a Giant Leap: Iambic Therapeutics Secures $100M

A Whiff of Hope: Could a Simple Nasal Spray Be Our Next Weapon Against Brain Cancer?

The Silent Toll: How Delayed Cancer Diagnoses Steal Futures, and the Beacon of Personalized Treatment

Urogen Pharma: Unpacking the Quiet Potential of ZUSDURI in Bladder Cancer

A Radical New Way to Fight Cancer: Precision Particles, Unprecedented Hope

The Unseen Architects of Survival: How Cancer Outwits Its Toughest Foes

The Surgical Question: When Less Might Be More for Advanced Kidney Cancer

A Grand Promise, A Tricky Map: Navigating Cancer with Antibody-Drug Conjugates

Triplets and Trade-offs: Navigating the New Frontier of Kidney Cancer Treatment

A Glimmer of Hope: Unpacking AMT-253's Early Promise Against Metastatic Melanoma

The Quiet Revolution: A New Hope Emerges for Advanced Breast Cancer

Unlocking New Hope: How Antibody-Drug Conjugates Are Changing the Face of Breast Cancer Treatment

$55 Million Reasons Why Your Specialty Pharmacy Experience is About to Get a Whole Lot Better: House Rx Steps Up

The Unflinching Hand at the Helm: Richard Pazdur's Enduring Legacy at the FDA

The Quiet Revolution: Bispecific Antibodies and the Shifting Landscape of Cancer Treatment

The Curious Case of ORIC Pharma: Why Wall Street Just Tipped Its Hand on a Potential Upside

Unraveling Cancer's Secret Symphony: The Tiny Teams Driving Disease

Breaking the Chemotherapy Chain: A New Era for Advanced Prostate Cancer

A Glimpse Into Tomorrow's Cures: Anixa Biosciences Prepares for a Revealing Fireside Chat

Two Biotech Stories, One Volatile Market: A Deep Dive into Gossamer and Precision

The Biotech Crossroads: Where Vor Biopharma and Liminatus Pharma Stand in the Race for Innovation

The Audacious Hope: Connecticut's Bold Bid to End Breast Cancer Deaths

The Unyielding Pursuit: Connecticut's Bold Stand Against Breast Cancer

A Glimmer of Hope: Monte Rosa's Groundbreaking Approach to Challenging Cancers

A Simple Antidote: Why the World Desperately Needs a Surge of Kindness, Right Now

Immunocore at the Crossroads: Steady Hands and the Search for Tomorrow's Breakthrough

The Dawn of Precision: Greater Noida's GIMS Embraces a Robotic Future

Beyond the Blade: A New Dawn for Prostate Cancer Treatment at CRHS

Navigating the Shifting Tides: A Look at Life Sciences in Q3 2025

Beyond the Horizon: How Compugen's COM701 is Quietly Redefining the Battle Against Cancer

The Myeloma Revolution: How New Science is Redefining Hope and Care

Beyond the Lab Coat: The Human-AI Partnership Charting a Course to Cancer's End

The Cancer Code: How One Biotech's 'Probody' Just Sparked Hope (and a Stock Surge)